“This ISO certification is a major step in our journey toward delivering ... of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in ...

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.

The Union cabinet approved the establishment of a Third Launch Pad at Satish Dhawan Space Centre, Sriharikota. This initiative aims to enhance ISRO's launch capacity for Next Generation Launch ...

The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...

Like New York Senator Chuck Schumer, who thinks the pouches need more federal oversight from the FTC and FDA, so kids don't get hooked. *** simple search of social media for Zen will generate an ...

The decision allows ZYN nicotine pouches to be legally marketed in the U.S. to adults aged 21 and older, the FDA said in a news release on Thursday ... ZYN to make reduced-risk claims without separate ...

A government watchdog examining the FDA’s accelerated approval pathway has released a 32-page report (PDF) that concludes the agency’s controversial endorsement of Biogen’s failed Alzheimer ...

The pouches have been available for more than a decade as FDA reviewed company data intended to show the products can serve as an alternative to cigarettes and other traditional tobacco products.

© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.

Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after 2 prior therapy failures. The FDA has granted approval to axatilimab-csfr ...

The FDA has approved Eli Lilly’s Omvoh (mirikizumab-mrkz) for the treatment of moderate to severe active Crohn's disease in adults according to a recent news release. This is its second indication. In ...

In 2024, the U.S. Food and Drug Administration (FDA) approved 50 new molecular entities, with 24 designated as first-in-class – will 2025 do better? For instance, cobenfy is the first new ...